AVITA Medical RCEL
NASDAQ RCEL
$12.72 +0.71 (+5.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021)

Updated

AVITA Medical's Asset Writedowns and Impairment came in at $4,000 for FY2023.

Analysis

AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021) Analysis & Trends

  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $42,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 AVITA Medical 393.39 Mn 325.07 Mn 17.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 19,000.00
Dec 31, 2020 -5,000.00
Sep 30, 2020 -77,000.00
Dec 31, 2019 11,000.00
Sep 30, 2019 8,000.00
API Access

AVITA Medical Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RCEL&period=max&api_key=YOUR_API_KEY